Clinical Trial Update: OM336 in Autoimmune Cytopenias [Phase 1]

View source ↗

Summary

Ouro Medicines reports a Phase 1 clinical trial of OM336 for autoimmune cytopenias, including warm and cold autoimmune hemolytic anemia and immune thrombocytope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Immune Thrombocytopenia

Drugs mentioned

• OM336

Snippet

Sponsor: Ouro Medicines | Conditions: AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia | Phase 1 | Status: RECRUITING